eli lilly glp-1 pill - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,973 +0.03%

DJIA 48,549 -0.02%

Nasdaq 25,869 +0.08%

DAX 24,021 -0.23%

Gold $4,196 +0.16%

Oil $88.45 -0.39%

BTC $73,729 -0.49%

VIX 20.38 -0.24%

EUR/USD 1.1785 -0.02%

ETH $2,316 +0.09%

S&P 500 6,973 +0.03%

DJIA 48,549 -0.02%

Nasdaq 25,869 +0.08%

DAX 24,021 -0.23%

Gold $4,196 +0.16%

Oil $88.45 -0.39%

BTC $73,729 -0.49%

VIX 20.38 -0.24%

EUR/USD 1.1785 -0.02%

ETH $2,316 +0.09%

eli lilly glp-1 pill

Eli Lilly GLP-1 pill concept in a modern lab symbolizing new obesity drug Foundayo

Pharma & Healthcare·Stocks·USA

Eli Lilly GLP-1 pill Foundayo: Can the Boom Last?

By Maik Kemper • Apr 13, 2026

Eli Lilly GLP-1 pill concept in a modern lab symbolizing new obesity drug Foundayo

Pharma & Healthcare·Stocks·USA

Eli Lilly GLP-1 pill Foundayo: Can the Boom Last?

By Maik Kemper • Apr 13, 2026

Can the new Eli Lilly GLP-1 pill Foundayo justify the stock’s rich valuation and extend its obesity drug dominance? Maik Kemper Editor in Chief Conclusion…